Autilion AG Invests $36 Million Into VistaGen Therapeutics, Inc.

... our labs presented during the Annual Meetings of the Society of Toxicology and International Society of Stem Cell Research in March and this month, respectively, we look forward to accelerating our lead programs towards valuable outcomes for our ...

http://www.biospace.com/news_story.aspx?StoryID=301462&full=1